Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Thomas

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Chirurgie (Heidelberg, Germany)|May 9, 2025
[Robotic liver surgery]Michael N Thomas, Thomas Schmidt, Hans Fuchs, et al.
Plos One|November 8, 2016
Multiparametric Functional MRI: A Tool to Uncover Subtle Changes following Allogeneic Renal TransplantationMike Notohamiprodjo, Aivars Kalnins, Martin Andrassy, et al.
Innovative Surgical Sciences|October 4, 2019
Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horsesHanno Niess, Michael N Thomas, Tobias S Schiergens, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 13, 2015
Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurementsMichael N Thomas, Ernst Weninger, Martin Angele, et al.
Surgical Endoscopy|March 2, 2011
Laparoscopic anterior hemifundoplication and hiatoplasty for the treatment of upside-down stomach: mid- and long-term results after 40 patientsFiras W Obeidat, Reinhold A Lang, Andreas Knauf, et al.
Transplant Immunology|January 7, 2023
The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic interventionMartin Ryll, Yutian Lei, Michael N Thomas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2016
Time-dependent impact of age and comorbidities on long-term overall survival after liver resectionTobias S Schiergens, Andrea Lindenthaler, Michael N Thomas, et al.
BMC Cancer|April 17, 2015
Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trialHanno Niess, Jobst C von Einem, Michael N Thomas, et al.
Oxidative Medicine and Cellular Longevity|August 17, 2017
Modulation of Glutathione Hemostasis by Inhibition of 12/15-Lipoxygenase Prevents ROS-Mediated Cell Death after Hepatic Ischemia and ReperfusionMoritz Drefs, Michael N Thomas, Markus Guba, et al.
Journal of Visualized Experiments : Jove|November 19, 2019
Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff TechniqueMartin Ryll, Julian Bucher, Moritz Drefs, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Chirurgie (Heidelberg, Germany)|May 9, 2025
[Robotic liver surgery]Michael N Thomas, Thomas Schmidt, Hans Fuchs, et al.
Plos One|November 8, 2016
Multiparametric Functional MRI: A Tool to Uncover Subtle Changes following Allogeneic Renal TransplantationMike Notohamiprodjo, Aivars Kalnins, Martin Andrassy, et al.
Innovative Surgical Sciences|October 4, 2019
Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horsesHanno Niess, Michael N Thomas, Tobias S Schiergens, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 13, 2015
Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurementsMichael N Thomas, Ernst Weninger, Martin Angele, et al.
Surgical Endoscopy|March 2, 2011
Laparoscopic anterior hemifundoplication and hiatoplasty for the treatment of upside-down stomach: mid- and long-term results after 40 patientsFiras W Obeidat, Reinhold A Lang, Andreas Knauf, et al.
Transplant Immunology|January 7, 2023
The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic interventionMartin Ryll, Yutian Lei, Michael N Thomas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2016
Time-dependent impact of age and comorbidities on long-term overall survival after liver resectionTobias S Schiergens, Andrea Lindenthaler, Michael N Thomas, et al.
BMC Cancer|April 17, 2015
Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trialHanno Niess, Jobst C von Einem, Michael N Thomas, et al.
Oxidative Medicine and Cellular Longevity|August 17, 2017
Modulation of Glutathione Hemostasis by Inhibition of 12/15-Lipoxygenase Prevents ROS-Mediated Cell Death after Hepatic Ischemia and ReperfusionMoritz Drefs, Michael N Thomas, Markus Guba, et al.
Journal of Visualized Experiments : Jove|November 19, 2019
Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff TechniqueMartin Ryll, Julian Bucher, Moritz Drefs, et al.
Pageof 3